ICU Medical Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $124.15
- Today's High:
- $129.535
- Open Price:
- $128.14
- 52W Low:
- $124.15
- 52W High:
- $212.43
- Prev. Close:
- $128.63
- Volume:
- 180670
Company Statistics
- Market Cap.:
- $3.10 billion
- Book Value:
- 87.737
- Revenue TTM:
- $2.29 billion
- Operating Margin TTM:
- 2.5%
- Gross Profit TTM:
- $697.76 million
- Profit Margin:
- -2.11%
- Return on Assets TTM:
- 0.79%
- Return on Equity TTM:
- -2.31%
Company Profile
ICU Medical Inc had its IPO on 1992-03-31 under the ticker symbol ICUI.
The company operates in the Healthcare sector and Medical Instruments & Supplies industry. ICU Medical Inc has a staff strength of 14,500 employees.
Stock update
Shares of ICU Medical Inc opened at $128.14 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $124.15 - $129.54, and closed at $124.5.
This is a -3.21% slip from the previous day's closing price.
A total volume of 180,670 shares were traded at the close of the day’s session.
In the last one week, shares of ICU Medical Inc have slipped by -14.05%.
ICU Medical Inc's Key Ratios
ICU Medical Inc has a market cap of $3.10 billion, indicating a price to book ratio of 1.9205 and a price to sales ratio of 1.8571.
In the last 12-months ICU Medical Inc’s revenue was $2.29 billion with a gross profit of $697.76 million and an EBITDA of $285.94 million. The EBITDA ratio measures ICU Medical Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, ICU Medical Inc’s operating margin was 2.5% while its return on assets stood at 0.79% with a return of equity of -2.31%.
In Q2, ICU Medical Inc’s quarterly earnings growth was a negative -23.8% while revenue growth was a negative 2.1%.
ICU Medical Inc’s PE and PEG Ratio
- Forward PE
- 20.284
- Trailing PE
- 0
- PEG
- 1.3453
Its diluted EPS in the last 12-months stands at $-1.96 per share while it has a forward price to earnings multiple of 20.284 and a PEG multiple of 1.3453. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into ICU Medical Inc’s profitability.
ICU Medical Inc stock is trading at a EV to sales ratio of 2.6224 and a EV to EBITDA ratio of 29.2243. Its price to sales ratio in the trailing 12-months stood at 1.8571.
ICU Medical Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $4.46 billion
- Total Liabilities
- $483.88 million
- Operating Cash Flow
- $-17606000.00
- Capital Expenditure
- $20.40 million
- Dividend Payout Ratio
- 0%
ICU Medical Inc ended 2024 with $4.46 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $4.46 billion while shareholder equity stood at $2.11 billion.
ICU Medical Inc ended 2024 with $89.68 million in deferred long-term liabilities, $483.88 million in other current liabilities, 2411000.00 in common stock, $817.76 million in retained earnings and $1.46 billion in goodwill. Its cash balance stood at $195.89 million and cash and short-term investments were $197.70 million. The company’s total short-term debt was $40,375,000 while long-term debt stood at $1.60 billion.
ICU Medical Inc’s total current assets stands at $1.24 billion while long-term investments were $0.00 and short-term investments were $1.81 million. Its net receivables were $162.23 million compared to accounts payable of $167.05 million and inventory worth $775.27 million.
In 2024, ICU Medical Inc's operating cash flow was $-17606000.00 while its capital expenditure stood at $20.40 million.
Comparatively, ICU Medical Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $124.5
- 52-Week High
- $212.43
- 52-Week Low
- $124.15
- Analyst Target Price
- $213
ICU Medical Inc stock is currently trading at $124.5 per share. It touched a 52-week high of $212.43 and a 52-week low of $212.43. Analysts tracking the stock have a 12-month average target price of $213.
Its 50-day moving average was $156.59 and 200-day moving average was $169.73 The short ratio stood at 4.55 indicating a short percent outstanding of 0%.
Around 1618.7% of the company’s stock are held by insiders while 9508.6% are held by institutions.
Frequently Asked Questions About ICU Medical Inc
Similar Industry Stocks (Medical Instruments & Supplies)
Most Active
Top Gainers
Top Losers
About
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; and ClearGuard HD, that maintains hemodialysis catheters. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer’s, ringer’s, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer’s irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 brand; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform that connects smart pumps to hospital’s electronic health records, asset tracking systems, and alarm notification platforms; professional services; critical care products, such as Cogent 2-in-1 and CardioFlo hemodynamic monitoring systems; TDQ and OptiQ cardiac output monitoring catheters; TriOx venous oximetry catheters; Transpac blood pressure transducers; and SafeSet closed blood sampling and conservation systems. The company’s customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California.